Palavra-chave: T-CELL LYMPHOMA

FIRST-LINE THERAPY COHORT STUDY OUTCOME OF PHERIPHERAL TCELL BRAZIL PROJECT T-CELL PROJECT PATIENTS FAILING RANDOMIZED PHASE III STUDY TREATMENT PROSPECTIVE COHORT PRIMARY REFRACTORY ALISERTIB T-CELL BRAZIL PROJECT T-CELL LYMPHOMA PROJECT EXTRANODAL NATURAL KILLER PROGNOSIS